|
Originally published In Press as doi:10.1074/jbc.M203888200 on August 2, 2002
J. Biol. Chem., Vol. 277, Issue 41, 38373-38380, October 11, 2002
G Protein-independent Activation of an Inward Na+
Current by Muscarinic Receptors in Mouse Pancreatic -Cells*
Jean-François
Rolland,
Jean-Claude
Henquin, and
Patrick
Gilon
From the Unité d'Endocrinologie et Métabolisme,
University of Louvain, Faculty of Medicine, UCL 55.30, Avenue
Hippocrate 55, B-1200 Brussels, Belgium
Received for publication, April 22, 2002, and in revised form, July 12, 2002
 |
ABSTRACT |
Depolarization of pancreatic -cells is
critical for stimulation of insulin secretion by acetylcholine but
remains unexplained. Using voltage-clamped -cells, we identified a
small inward current produced by acetylcholine, which was suppressed by
atropine or external Na+ omission, but was not
mimicked by nicotine, and was insensitive to nicotinic antagonists,
tetrodotoxin, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid
(DiDS), thapsigargin pretreatment, and external Ca2+
and K+ removal. This suggests that muscarinic receptor
stimulation activates voltage-insensitive Na+ channels
distinct from store-operated channels. No outward Na+
current was produced by acetylcholine when the electrochemical Na+ gradient was reversed, indicating that the channels are
inward rectifiers. No outward K+ current occurred either,
and the reversal potential of the current activated by acetylcholine in
the presence of Na+ and K+ was close to that
expected for a Na+-selective membrane, suggesting that the
channels opened by acetylcholine are specific for Na+.
Overnight pretreatment with pertussis toxin or the addition of
guanosine 5'-O-(3-thiotriphosphate) (GTP- -S) or
guanosine-5'-O-(2-thiodiphosphate) (GDP- -S) instead of
GTP to the pipette solution did not alter this current, excluding
involvement of G proteins. Injection of a current of a similar
amplitude to that induced by acetylcholine elicited electrical activity
in -cells perifused with a subthreshold glucose concentration. These
results demonstrate that muscarinic receptor activation in pancreatic
-cells triggers, by a G protein-independent mechanism, a selective
Na+ current that explains the plasma membrane depolarization.
 |
INTRODUCTION |
During the feeding periods, the increase in glycemia is limited in
time and amplitude by the hypoglycemic action of insulin. Blood glucose
itself is the main stimulator of insulin secretion by pancreatic
-cells. This stimulation involves two complementary pathways.
Glucose generates a triggering signal, a rise in cytosolic Ca2+ concentration
([Ca2+]c),1
through the following sequence of events: the acceleration of cell
metabolism increases the ATP/ADP ratio, which closes ATP-sensitive K+ (K+-ATP) channels in the plasma membrane;
the resulting decrease in K+ conductance leads to membrane
depolarization, opening of voltage-dependent Ca2+ channels, and Ca2+ influx (1-5). Glucose
also produces amplifying signals that increase the efficacy of
Ca2+ on exocytosis (6, 7).
Besides glucose, physiological agents such as hormones and
neurotransmitters also modulate insulin secretion. A rich
parasympathetic and sympathetic innervation enters the islets and ends
close to the endocrine cells, allowing a fine neural tuning of the
islet function (8, 9). Acetylcholine (ACh) is released by
parasympathetic nerve endings during the preabsorptive phase of feeding
to enhance insulin secretion prior to the rise in plasma glucose and
during the absorptive phase (10). By binding to muscarinic receptors of
the M3 type, ACh triggers changes in phospholipid
metabolism leading to formation of diacylglycerol, which activates
protein kinase C, and inositol 1,4,5-trisphosphate, which mobilizes
Ca2+ from intracellular Ca2+ stores. The
resulting fall of the Ca2+ concentration in the endoplasmic
reticulum activates a modest Ca2+ influx, through
voltage-independent Ca2+ channels, which is commonly
referred to as a capacitative Ca2+ entry. In addition, ACh
depolarizes the plasma membrane of -cells. This depolarization is
small and does not cause Ca2+ influx in unstimulated
-cells. However, in the presence of stimulatory (depolarizing)
concentrations of glucose, this additional depolarization by ACh
enhances Ca2+ influx through voltage-dependent
Ca2+ channels, leading to a sustained
[Ca2+]c elevation (10).
Although central for the increase in insulin secretion by ACh (10, 11),
the depolarization has never been conclusively explained. Several
observations suggest that a Na+ current is involved. Thus,
the depolarization of -cells by ACh is abrogated by omission of
extracellular Na+ (12) and accompanied by increases in
total Na+ content (13), 22Na+
uptake (12, 14), and free cytosolic Na+ concentration
([Na+]c) (15). These arguments, however, remain
indirect and conflict with the general concept that nicotinic rather
than muscarinic receptors mediate cholinergic effects on
Na+ conductance. In the present study, we used membrane
potential recordings with microelectrode and both conventional and
perforated whole cell modes of the patch-clamp technique to identify
and characterize the current by which ACh depolarizes the plasma
membrane of mouse -cells. Our study provides the first direct
electrophysiological evidence for muscarinic, G protein-independent
stimulation of an inward Na+ current in pancreatic
-cells.
 |
EXPERIMENTAL PROCEDURES |
Preparation of Cells--
The pancreas from NMRI mice
killed by cervical dislocation was aseptically digested with
collagenase in a bicarbonate-buffered solution containing 120 mmol/liter NaCl, 4.8 mmol/liter KCl, 2.5 mmol/liter CaCl2,
1.2 mmol/liter MgCl2, 24 mmol/liter NaHCO3, 5 mmol/liter Hepes, 10 mmol/liter glucose, and 1 mmol/liter mg/ml bovine
serum albumin (fraction V; Roche Molecular Biochemicals) and gassed
with O2/CO2 (94:6%) to have a pH of 7.4. The
islets were handpicked under a stereomicroscope. Single cells were
obtained by incubating the islets for 5 min in a Ca2+-free
medium containing 138 mmol/liter NaCl, 5.6 mmol/liter KCl, 1.2 mmol/liter MgCl2, 5 mmol/liter Hepes, 3 mmol/liter glucose, and 1 mmol/liter EGTA (pH 7.4). After a brief centrifugation, this
solution was replaced by culture medium, and the islets were disrupted
by gentle pipetting through a siliconized glass pipette. The cells were
plated on 22-mm-diameter glass coverslips. Intact islets and single
islet cells were cultured for, respectively, 1 and 1-3 days in RPMI
1640 culture medium (Invitrogen) containing 10% heat-inactivated fetal
calf serum and 10 mmol/liter glucose. All of the solutions for tissue
preparation and culture medium were supplemented with 100 IU/ml
penicillin and 100 µg/ml streptomycin.
Electrophysiological Recordings--
The membrane potential of a
single -cell within an islet was continuously recorded at 37 °C
with a high resistance (~200 M ) intracellular microelectrode (16).
-Cells were identified by the typical electrical activity that they
display in the presence of 10 mmol/liter glucose.
Two criteria defined previously (17) were used to identify single
-cells: a cell capacitance above 5 pF and the presence of a
voltage-dependent Na+ current that is
inactivated at a holding potential of 70 mV but can be activated
after a hyperpolarizing pulse to 140 mV. Patch-clamp measurements
were carried out in both conventional and perforated whole cell modes,
using an EPC-9 patch-clamp amplifier (Heka Electronics,
Lambrecht/Pfalz, Germany) and the software Pulsefit or an Axopatch
200 B patch-clamp amplifier (Axon Instruments, Foster City, CA) and the
software pClamp 8. Patch pipettes were pulled from borosilicate glass
capillaries (World Precision Instruments, Inc., Hertfordshire, UK) to
give a resistance of 4-5 M . Except for the experiments performed to
obtain the I-V curve, INa-ACh was measured in cells kept
hyperpolarized at 80 mV. ICa was measured by applying
25-ms depolarizations from 80 mV to +10 mV every 5 s.
Voltage-clamp experiments were performed at room temperature (22-25 °C), whereas current-clamp experiments were carried out at
34-36 °C.
Solutions for Electrophysiological Recordings--
The standard
extracellular solution used for membrane potential recordings with
intracellular microelectrodes contained 122 mmol/liter NaCl, 4.7 mmol/liter KCl, 2.6 mmol/liter CaCl2, 1.2 mmol/liter
MgCl2, 20 mmol/liter NaHCO3, and 10 mmol/liter
glucose. It was gassed with O2/CO2 (95%:5%)
to maintain pH at 7.4.
Various solutions were used for patch-clamp recordings. In the
perforated mode, the pipette solution contained 70 mmol/liter K2SO4, 10 mmol/liter NaCl, 10 mmol/liter KCl,
3.7 mmol/liter MgCl2, and 5 mmol/liter Hepes (pH 7.1)
(Int Sol A). The electrical contact was established by
adding a pore-forming antibiotic, amphotericin B or nystatin, to the
pipette solution. Amphotericin (stock solution of 60 mg/ml in
Me2SO) was used at a final concentration of 300 µg/ml.
Nystatin (stock solution of 10 mg/ml in Me2SO) was used at
a final concentration of 200 µg/ml. The tip of the pipette was
back-filled with antibiotic-free solution, and the pipette was then
filled with the amphotericin- or nystatin-containing solution. The
voltage clamp was considered satisfactory when the series conductance
was >35-40 nS.
In conventional whole cell recordings of INa-ACh, the
pipette solution contained 112 mmol/liter KCl, 5 mmol/liter KOH, 1 mmol/liter MgCl2, 3 mmol/liter MgATP, 0.1 mmol/liter
Na2GTP, and 10 mmol/liter Hepes (pH adjusted to 7.15 with 1 mmol/liter HCl) (Int Sol B). When needed, 10 mmol/liter EGTA
was added to internal solution B (Int Sol C).
Na+-rich/K+-free solution was prepared by
substituting NaCl for KCl and NaOH for KOH of internal solution B
(Int Sol D). Na+-free/K+-rich
solution was prepared by increasing KCl and KOH concentrations of
internal solution B to 125 and 30, respectively (pH adjusted to 7.15 with 18 mmol/liter HCl) (Int Sol E). For experiments during which the equilibrium potential for Na+ was fixed at 60
or 20 mV, the pipette solution contained 107 mmol/liter NaCl, 10 mmol/liter NaOH, 3 mmol/liter MgATP, 0.1 mmol/liter Na2GTP,
1 mmol/liter MgCl2, and 10 mmol/liter Hepes (pH adjusted to
7.15 with 7 mmol/liter HCl) (Int Sol F). For conventional
whole cell recordings of ICa, the pipette solution
contained 125 mmol/liter CsCl, 30 mmol/liter KOH, 1 mmol/liter
MgCl2, 10 mmol/liter EGTA, 3 mmol/liter MgATP, 0.1 mmol/liter Na2GTP, and 5 mmol/liter Hepes (pH 7.15)
(Int Sol G). When specified, GTP- -S or GDP- -S was substituted for GTP in the pipette solution. When the conventional whole cell mode was used, ACh was applied 5 min after the rupture of
the plasma membrane.
The standard extracellular solution used to monitor INa-ACh
contained 120 mmol/liter NaCl, 4.8 mmol/liter KCl, 2.5 mmol/liter CaCl2, 1.2 mmol/liter MgCl2, 24 mmol/liter
NaHCO3, 5 mmol/liter Hepes (pH 7.4), and 10 mmol/liter
glucose (Ext Sol A). Ca2+-free solution was
prepared by substituting MgCl2 for CaCl2 of external solution A and was supplemented with 2 mmol/liter EGTA (Ext Sol B). When needed, Na+
145/K+-free solution was prepared by substituting NaCl for
KCl of external solution A (Ext Sol C).
Na+-free/K+ 4.8 solution contained 135 mmol/liter N-methyl-D-glucamine, 4.8 mmol/liter
KCl, 2.5 mmol/liter CaCl2, 1.2 mmol/liter
MgCl2, 5 mmol/liter Hepes (pH adjusted to 7.4 with 131 mmol/liter HCl), and 10 mmol/liter glucose (Ext Sol D). When
needed, Na+-K+-free solution was prepared by
substituting N-methyl-D-glucamine for KCl of
external solution D (pH adjusted to 7.4 with 136 mmol/liter HCl)
(Ext Sol E). For experiments during which the equilibrium potential for Na+ was fixed at 60 mV, the external
solution contained 11 mmol/liter NaCl, 10 mmol/liter KCl, 180 mmol/liter N-methyl-D-glucamine, 2.5 mmol/liter
CaCl2, 1.2 mmol/liter MgCl2, 5 mmol/liter Hepes (pH 7.4), 0.1 mmol/liter CdCl2, 0.25 mmol/liter tolbutamide
(pH adjusted to 7.4 with 172 mmol/liter HCl), and 10 mmol/liter glucose (Ext Sol F). For experiments during which the equilibrium
potential for Na+ was fixed at 20 mV, the external
solution contained 53 mmol/liter NaCl, 10 mmol/liter KCl, 100 mmol/liter N-methyl-D-glucamine, 2.5 mmol/liter
CaCl2, 1.2 mmol/liter MgCl2, 5 mmol/liter Hepes (pH 7.4), 0.1 mmol/liter CdCl2, 0.25 mmol/liter tolbutamide
(pH adjusted to 7.4 with 96 mmol/liter HCl), and 10 mmol/liter glucose (Ext Sol G). For recordings of ICa, the external
solution contained 125 mmol/liter NaCl, 4.8 mmol/liter KCl, 10 mmol/liter CaCl2, 1.2 mmol/liter MgCl2, 10 mmol/liter tetraethylammonium-Cl, 5 mmol/liter Hepes (pH 7.4), and 10 mmol/liter glucose (Ext Sol H).
Thapsigargin was obtained from Alomone Labs (Jerusalem, Israel). Unless
otherwise stated, all of the other chemicals were from Sigma.
Presentation of Results--
The experiments are illustrated by
means or representative traces of results obtained with the indicated
number of cells from at least three different cultures. The statistical
significance of differences between means was assessed by unpaired
Student's t test. Differences were considered significant
at p < 0.05.
 |
RESULTS |
Effects of ACh on the Membrane Potential of Mouse Pancreatic
-Cells--
In the presence of 10 mmol/liter glucose, -cells
within an islet display a rhythmic electrical activity characterized by alternating polarized silent phases and depolarized phases with bursts
of action potentials (Fig. 1). The
addition of 1 µmol/liter ACh induced a sustained and persistent
depolarization with continuous spike activity in two of six islets. In
the other islets, the initial period of sustained activity was followed
by rapid oscillations of the membrane potential (Fig. 1). Similar
effects of ACh on the -cell electrical activity have previously been
observed in noncultured islets and are blocked by atropine (12,
18).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Effects of ACh on the membrane potential of a
mouse -cell. An isolated islet was
perifused with a medium containing 10 mmol/liter glucose
(G10) and stimulated with 1 µmol/liter ACh as indicated.
This recording is representative of results obtained in six
islets.
|
|
Muscarinic Receptor Activation Induces an Inward Current in
-Cells--
The effect of ACh on the whole cell current was first
studied in single -cells held hyperpolarized at 80 mV by the
conventional whole cell configuration of the patch-clamp technique.
Addition of ACh induced a sustained and reversible inward current, the amplitude of which increased with the concentration of the
neurotransmitter (Fig. 2,
A-D) to reach a maximum of 0.77 ± 0.15 pA/pF
(n = 5) at 100 µmol/liter ACh. The half-maximal
effective concentration (EC50) estimated after fitting the
data to a sigmoidal function was at 2.5 µmol/liter ACh (Fig.
2D). The kinetics of activation of the current by ACh could
not be established reliably because the characteristics of our
perifusion system (chamber volume of ~0.8 ml and flow rate of ~0.5
ml/min) preclude fast solution exchange. However, it was repeatedly
noted that the current activated by ACh developed rapidly, within ~1
s (Figs. 2B and
3G), in cells that were
located very close to the inflow of solution and more slowly (Fig. 3,
B and D) in cells that were located at some
distance of this inflow.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
ACh induces an inward current by activating
muscarinic receptors in mouse -cells.
Single -cells were voltage-clamped at 80 mV using the conventional
(A-D) or the perforated (E) whole cell mode of
the patch-clamp technique. The composition of the external (Ext
Sol) and pipette solutions (Int Sol) used is described
under "Experimental Procedures." ACh and atropine were applied when
indicated by the arrows. A-D, ACh induced a
concentration-dependent inward current that was reversed or
blocked by atropine. A-C are representative of three
(A), three (B), and four (C)
experiments. D shows the concentration-dependence of
ACh-induced inward current. The values are the means ± S.E. of
the amplitude of the current recorded in three to five cells for each
ACh concentration. Fitting data points to a sigmoidal function yielded
a half-maximal effective concentration (EC50) of 2.5 µmol/liter. E, pretreatment of intact -cells by
thapsigargin (30 min, 1 µmol/liter) did not prevent ACh from
activating an inward current. This trace is representative of five
experiments.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Characteristics of the inward current
activated by ACh in mouse -cells. Single
-cells were voltage-clamped at 80 mV using the conventional whole
cell mode of the patch-clamp technique. The composition of the external
(Ext Sol) and pipette solutions (Int Sol) used
for these experiments is described under "Experimental Procedures."
For the sake of clarity, their main characteristics are summarized on
the left side of each panel. ACh (100 µmol/liter) was
applied when indicated by the arrows. A and
B, ACh induced an inward current in the absence of
Ca2+ in the external and pipette solutions
(Caout 0, Cain 0) (A) or when the
Na+/K+ pump was blocked by removal of
K+ from the external solution (Kout 0)
(B). C and D, the inward current
activated by ACh was abrogated by Na+ omission from the
medium (Naout 0) (C) but unaffected by
inhibition of voltage-dependent Na+ channels
with 2 µmol/liter tetrodotoxin (D). E and
F, ACh failed to induce an outward current when the driving
force for Na+ was directed outwardly (Naout 0;
Nain-rich) (E) or when the driving force for
K+ was directed outwardly (Kout 0;
Kin-rich) and, simultaneously, no Na+ current
could occur (Naout 0; Nain 0) (F).
G, 100 µmol/liter DIDS did not affect the inward current
elicited by ACh. The traces are representative of at least five
experiments.
|
|
The current elicited by ACh was completely suppressed or prevented by
the muscarinic receptor antagonist, atropine (Fig. 2, A-C),
but was not mimicked by 10 µmol/liter nicotine (n = 5, not shown), and was insensitive to nicotine or nicotinic
antagonists. Thus, in the presence of 10 µmol/liter nicotine, 0.1 µmol/liter -bungarotoxin, or 100 µmol/liter hexamethonium, 100 µmol/liter ACh elicited a current that was, respectively, 90 ± 8% (n = 11), 111 ± 11% (n = 6),
or 107 ± 6% (n = 7) of the current activated by
ACh in the absence of nicotinic agents. These experiments show that the
ACh-induced inward current in -cells results from activation of
muscarinic, but not nicotinic, receptors.
In another series of experiments, -cells were voltage-clamped in the
perforated whole cell mode and treated with 1 µmol/liter thapsigargin, which completely emptied the endoplasmic reticulum in
Ca2+, as indicated by the suppression of Ca2+
mobilization by ACh (n = 5; not shown). Subsequent
application of ACh elicited a current of the same amplitude (0.77 ± 0.09 pA/pF, n = 11) as that measured in the whole
cell configuration (Fig. 2E). The ACh-induced inward
current, therefore, is not a store-operated current.
Characteristics of the Current Activated by ACh in
-Cells--
The ionic specificity of the current was first
evaluated in the standard whole cell mode by removing Ca2+,
Na+, or K+ from the bath or pipette solutions.
Addition of ACh to a Ca2+-free medium elicited an inward
current, indicating that the latter was not carried by Ca2+
(Fig. 3A). Omission of K+ from the perifusion
medium did not prevent the current elicited by ACh, indicating that the
current does not involve changes in Na+ pump activity (Fig.
3B). By contrast, omission of extracellular Na+
abrogated the current, which suggests that it is carried by
Na+ (Fig. 3C). The current was nevertheless
insensitive to tetrodotoxin, indicating that voltage-gated
Na+ channels are not involved (Fig. 3D). When
the electrochemical gradient for Na+ was reversed
(Na+-rich pipette solution and Na+-free bath
medium) to permit an outward current, ACh was ineffective (Fig.
3E), suggesting that Na+ flows only in the
inward direction.
A nonspecific cationic current carrying both Na+ and
K+ could also depolarize the plasma membrane because it
usually has a reversal potential close to 0 mV. The experiments
performed above did not allow us to exclude the possibility that ACh
activates such a current because either the membrane was clamped close
to the equilibrium potential of K+ (Fig. 3C) or
no K+ was present in the pipette and bath solutions (Fig.
3E). To address that question, two series of experiments
were thus performed. In the first series, Na+ was omitted
from both pipette and bath solutions, whereas K+ was
present at a high concentration in the pipette solution only (Fig.
3F). Under these conditions where the equilibrium potential for K+ was infinitely negative and no Na+
current could occur, ACh did not activate any outward current. In the
second series of experiments, the Na+ versus
K+ specificity of the current activated by ACh was
evaluated by measuring its reversal potential with pipette and external
solutions selected to have very different equilibrium potentials for
Na+ and K+, i.e. 60 or 20 mV for
Na+, and infinitely positive potentials for K+.
These experiments were performed in the presence of Cd2+ to
block voltage-dependent Ca2+ channels (and
avoid [Ca2+]c overload or activation of
Ca2+-dependent currents) and tolbutamide to
block K+-ATP channels (and avoid a large outward current
through these channels). However, even under these conditions, the
reversal potential could not be reliably estimated by voltage ramp
protocols because of the smallness of the current. Therefore, the
effect of ACh was tested in separate -cells held at selected fixed
potentials between 130 and 0 mV (Fig.
4). Experiments at potentials more negative than 130 mV or more positive than 0 mV could not be performed because of instability of the seal. Pipette and external solutions were first selected to have an equilibrium potential for
Na+ at 60 mV. At potentials more negative than 60 mV,
the amplitude of the inward current induced by ACh increased with the
driving force for Na+ (larger at 130 than 100 mV) and
displayed a slope conductance of 6.6 pS/pF (Fig. 4, open
squares). At the set equilibrium potential for Na+
( 60 mV), ACh did not induce any current. To test whether the reversal
potential of the current activated by ACh strictly followed the
equilibrium potential of Na+, the equilibrium potential of
Na+ was then fixed at 20 mV. At this potential, ACh
failed to activate any current. However, at potentials more negative
than 20 mV, ACh induced an inward current with an amplitude
proportional to the driving force for Na+ and with a slope
conductance of 5.3 pS/pF (Fig. 4, filled circles). All these
results clearly indicate selectivity for Na+ without
contribution of K+. Because of this ionic characteristic,
the current will be referred to as INa-ACh. At potentials
less negative than the set equilibrium potential for Na+
( 30 and 0 mV when ENa was fixed at 60 mV; 0 mV when
ENa was fixed at 20 mV), ACh did not activate any outward
current (Fig. 4), which, together with the results of Fig.
3E, suggests that the channels responsible for
INa-ACh are inward rectifiers.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 4.
The current activated by ACh in mouse
-cells is rectifying inwardly. The reversal
potential for Na+ was fixed at 60 mV (open
squares) or 20 mV (closed circles) by using external
(Ext Sol) and pipette solutions (Int Sol) with
appropriate concentrations of Na+ (see "Experimental
Procedures" for compositions). Single -cells were voltage-clamped
in conventional whole cell mode at various potentials ( 130, 100,
60, 30, and 0 mV when ENa+ was set at 60
mV and 100, 60, 20, and 0 mV when ENa+
was set at 20 mV) around the reversal potential for Na+.
Each point shows the mean ± S.E. of the current amplitude
elicited by 100 µmol/liter of ACh at each potential in three to five
cells.
|
|
An increase in Cl permeability is expected to depolarize
the plasma membrane because the equilibrium potential for
Cl in -cells has been estimated to be above the
threshold for activation of voltage-dependent
Ca2+ channels (19, 20). Activation of a Cl
current by ACh has not been directly tested by omitting
Cl from the medium. However, this possibility can also be
discarded for two reasons. First, ACh did not elicit any current when
the membrane was clamped at a potential different from the equilibrium potential of Cl and under conditions where no
Na+ current occurred (e.g. at holding potentials
of 80, 80, and 60 mV in Figs. 3 (C and F)
and 4 (open squares), when ECl was at, 6, 0, and 14 mV, respectively). Second, INa-ACh was unaffected by DIDS, a blocker of the volume-activated current (21) that carries
Cl and possibly other ions in -cells (22). Thus, in
the presence of 100 µmol/liter DIDS, 100 µmol/liter ACh
elicited a current that was 112 ± 10% (n = 14)
of the current activated by ACh in the absence of the
blocker (Fig. 3G).
Activation of INa-ACh Does Not Involve G
Proteins--
Muscarinic effects of ACh in -cells are known or
assumed to be transduced by a G protein, and it has been reported that
in neurons and cardiomyocytes, several muscarinic receptor subtypes modulate ionic channels, such as Ca2+ and K+
channels, through pertussis toxin-sensitive G proteins of the Gi or Go class (10). However, after permanent
inactivation of Gi or Go proteins by overnight
pretreatment of -cells with pertussis toxin (250 ng/ml), the
amplitude of INa-ACh was 109 ± 7% (n = 6) of that observed in untreated cells. To test the possible
involvement of all kinds of G proteins in the activation of
INa-ACh, GTP in the pipette solution (control conditions)
was replaced by GTP- -S or GDP- -S, which are, respectively,
nonhydrolyzable activator and inhibitor of G proteins. Fig.
5 shows the maximum inward current (INa-ACh) elicited by a 1-min application of 100 µmol/liter ACh to -cells voltage-clamped at 80 mV and dialyzed
for 5 min with a solution containing 100 µmol/liter GTP, 10 µmol/liter GTP- -S, or 4 mmol/liter GDP- -S. In all conditions,
INa-ACh was reversible upon washout of the
neurotransmitter, and its amplitude was similar with the three
nucleotides, suggesting that activation of INa-ACh does not
involve G proteins.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Activation of INa-ACh in
mouse -cells does not involve G proteins.
Single mouse -cells were voltage-clamped at 80 mV and dialyzed
with a pipette solution (Int Sol B; see "Experimental
Procedures" for compositions) containing 100 µmol/liter GTP
(Control), 10 µmol/liter GTP- -S, or 4 mmol/liter
GDP- -S. Each column represents the mean ± S.E. of the current
amplitude elicited by 100 µmol/liter ACh in nine
(Control), five (GTP- -S), and four (GDP- -S)
cells.
|
|
To ascertain that our experimental conditions were adequate to identify
the involvement of a G protein, we tested the GTP analogues on the
ACh-induced inhibition of voltage-dependent
Ca2+ current in pancreatic -cells (23). Fig.
6A shows representative whole
cell Ca2+ current traces recorded with a pipette solution
containing 100 µmol/liter GTP. The current (ICa) was
evoked by 25-ms depolarizing pulses from 80 to 10 mV before
(control), during (ACh), and after (wash) application of 100 µmol/liter ACh to the bath. Fig. 6B summarizes the changes
of the normalized peak Ca2+ current produced by ACh in the
presence of different guanine nucleotides in the pipette solution. With
100 µmol/liter GTP in the pipette solution (control), ACh reversibly
inhibited the current. This inhibitory effect was abolished when the
pipette solution contained 4 mmol/liter GDP- -S and became
irreversible when 10 µmol/liter GTP- -S was included in the
pipette. The spontaneous decrease in the current amplitude recorded
with GDP- -S reflects rundown (23). These control experiments thus
show that the guanine nucleotides were effective in our recording
conditions.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Inhibition of ICa by ACh in
mouse -cells involves G proteins. Single
-cells were dialyzed with a pipette solution (Int Sol G;
see "Experimental Procedures" for compositions) containing 100 µmol/liter GTP (Control), 10 µmol/liter GTP- -S, or 4 mmol/liter GDP- -S, and submitted to a 25-ms depolarization to +10 mV
from a holding potential of 80 mV. A, representative
voltage-dependent Ca2+ currents recorded with a
pipette solution containing 100 µmol/liter GTP before
(Control), during (ACh 100 µmol/l), and after
(Wash) addition of ACh to the perifusion medium.
B, time course of the effect of ACh on the peak
ICa recorded with different guanine nucleotides in the
pipette solution. Open squares, GTP; closed
triangles, GTP- -S; closed circles, GDP- -S. To
facilitate comparisons, ICa was normalized in each
individual experiment by dividing the peak current at each time by the
maximum peak current at time 0. The traces are the means ± S.E.
of results obtained in six cells for each experimental condition.
|
|
Impact of a Depolarizing Current Equivalent to INa-ACh
on the -Cell Membrane Potential--
Because INa-ACh is
small, it was important to verify that a current of a similar amplitude
was sufficient to elicit electrical activity. These experiments were
performed in -cells perifused at 34-36 °C with 6 mmol/liter
glucose, a concentration that is subthreshold in islets (24). A
depolarizing current corresponding to the average INa-ACh
induced by 100 µmol/liter ACh (0.77 pA/pF) and adjusted to cell size
(0.77 pA × capacitance of the tested cell) was injected in the
current-clamp mode. Such a current elicited an electrical activity in
all tested cells, and its removal was accompanied by an immediate
repolarization (Fig. 7A). In
other experiments shown in Fig. 7B, the depolarizing effect
of 1 µmol/liter ACh was first tested and compared with that of
depolarizing currents corresponding to INa-ACh elicited by
1 (0.23 pA/pF), 10 (0.61 pA/pF), and 100 µmol/liter ACh (0.77 pA/pF).
The addition of 1 µmol/liter ACh triggered electrical activity with
action potentials that ceased upon washout of the neurotransmitter.
Subsequent injection of a current with an amplitude similar to that of
INa-ACh induced by 1 µmol/liter ACh (a in Fig.
7B) elicited electrical activity similar to that produced by
1 µmol/liter ACh itself. Injection of larger currents corresponding
to INa-ACh induced by 10 and 100 µmol/liter ACh
(b and c, respectively, in Fig. 7B)
augmented the frequency of the electrical activity. These results
indicate that the small INa-ACh is sufficient to depolarize
the membrane potential beyond the threshold for the activation of
voltage-dependent Ca2+ channels.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
Injection of a depolarizing current mimics
the ACh effects on the -cell membrane
potential. The membrane potential of a single mouse -cell was
monitored in current-clamp mode of the patch-clamp technique. The
concentration of glucose of the medium was 6 mmol/liter throughout. No
current (0) was injected into the cell except for the periods indicated
by upward deflections of the traces above each panel. In A,
injection of a current with an amplitude corresponding to that elicited
by 100 µmol/liter ACh (0.77 pA × 10.4 pF = 8 pA in this
cell) elicited an electrical activity characterized by action
potentials on top of a plateau phase. In B, the cell was
first stimulated with 1 µmol/liter ACh. A current was then injected
at increasing amplitudes corresponding to those of the inward currents
elicited by 1 (0.23 pA × 8.7 pF = 2 pA in this cell;
period a), 10 (0.61 × 8.7 pF = 5 pA; period
b), and 100 µmol/liter ACh (0.77 × 8.7 pF = 7 pA;
period c). Injection of the smallest current mimicked the
effect of 1 µmol/liter ACh. These traces are representative of four
(A) and five (B) experiments.
|
|
 |
DISCUSSION |
By activating muscarinic receptors, ACh induces a number of
effects in pancreatic -cells that culminate in an increase in insulin secretion (10). Among these effects, a
glucose-dependent depolarization of the plasma membrane
plays a central role. Experiments using intracellular microelectrodes
and tracer fluxes have led to the suggestion that a Na+
current underlies the ACh-mediated depolarization (12). This proposal
has, however, remained incompletely convincing because Na+
currents are classically activated by nicotinic rather than muscarinic receptors and because the predicted ionic mechanism has not received direct electrophysiological support. The present study eventually succeeded in identifying an inward current that is specifically carried
by Na+ and is responsible for the muscarinic depolarization
of pancreatic -cells. It further shows that the activation of the
current is not mediated by G proteins.
Acetylcholine Activates an Inward Na+ Current in
-Cells--
Our data demonstrate that ACh activates an inward
current that is attributed to Na+ influx because of
its suppression either when Na+ was removed from the
extracellular medium or when the membrane potential of the cell was
close to the equilibrium potential of Na+. On the other
hand, no contribution of Ca2+, K+, or
Cl to the current could be obtained. Thus, the
ACh-induced current was not affected by removal of extracellular
Ca2+. When no Na+ current could occur, no
inward or outward current was evoked by ACh, even when the equilibrium
potential of K+ was infinitely negative or positive or when
the membrane potential was clamped away from the equilibrium potential
of Cl . The current elicited by ACh was also insensitive
to DIDS, a blocker of the Cl -mediated, volume-activated
current in -cells (22).
Activation of this Na+ current by ACh may explain the
increase in total Na+ content (13),
22Na+ uptake (12, 14), and
[Na+]c (15) that the neurotransmitter induces in
islet cells and the abrogation of all of these effects in a
Na+-free medium. The amplitude of the Na+
current elicited by ACh is small but is sufficient to account for the
15-mmol/liter increase in [Na+]c occurring in
-cells after 15 min of stimulation with 100 µmol/liter ACh (15,
25). Indeed, 100 µmol/liter ACh activated a mean inward current of
0.77 pA/pF, which corresponds to 6.15 pA for an average -cell
capacitance of 7.9 ± 0.08 pF (estimated from 644 -cells tested
in the present study). Assuming that the current remains stable over 15 min, the current charge amounts to 5537 pCb, which corresponds to ~57
fmol of Na+. For an intracellular space of 620 fl/ -cell (26), this would result in a
[Na+]c increase by 92 mmol/liter, which is well
above the 15 mmol/liter measured. Activation of the Na+
pump obviously tends to correct the [Na+]c rise.
The reverse mechanism, an inhibition of the Na+ pump, has
been proposed to explain the increase in [Na+]c
produced by ACh in sheep Purkinje fibers (27). The explanation does not
hold for -cells in which ACh still increases [Na+]c after blockade of the pump by ouabain
(15). This is fully compatible with the persistence of the ACh-induced
inward current in a K+-free medium, another situation where
the Na+ pump is blocked.
Nicotinic receptors, which are nonselective cationic channels (28, 29),
classically mediate cholinergic effects on Na+ currents.
Such channels are clearly not responsible for the ACh-induced inward
current in -cells because the muscarinic antagonist atropine completely prevented the current and the rise in
[Na+]c (15), whereas the ACh-activated current
was not mimicked by nicotine and was insensitive to nicotinic
antagonists. Activation of a Na+ conductance by muscarinic
receptors is unusual but has occasionally been reported in cardiac
myocytes (30, 31), smooth muscle cells of the gastro-intestinal tract
(32, 33), chromaffin cells (34), and Chinese hamster ovary cells
expressing M3 receptors (35).
The channels activated by ACh in -cells have not been identified,
but several of their properties could be established.
Voltage-dependent Na+ channels are present in
mouse -cells, but they are inactivated at the holding potential of
80 mV that we used (36). We can discard the possibility that such
channels mediate the effect of ACh because the Na+ current
evoked by the neurotransmitter did not require any voltage change and
was insensitive to tetrodotoxin, as are the ACh-induced increases in
Na+ uptake (12) and [Na+]c (15). Our
results also indicate that the current is not carried by a nonspecific
cationic channel allowing flow of both Na+ and
K+ or Ca2+. The Na+ channels
activated by ACh display inward rectifying properties as shown by their
inability to carry an outward current when the electrochemical gradient
for Na+ was reversed. Because the inward current activated
by ACh is a specific Na+ current, we termed it
INa-ACh.
Mechanisms of Activation of INa-ACh--
As in other
cells (37, 38), lowering the Ca2+ content of the
endoplasmic reticulum in -cells activates conductances for Ca2+ and perhaps other ionic species including
Na+ (25, 39). Even if such a mechanism slightly contributes
to the current, it is not responsible for INa-ACh, because
ACh still activated the inward current after emptying of the
endoplasmic reticulum Ca2+ stores by thapsigargin. This is
consistent with our previous report that thapsigargin and cyclopiazonic
acid, which empty the endoplasmic reticulum in Ca2+ more
efficiently than does ACh, did not mimic or prevent the [Na+]c rise elicited by ACh (25). The fact that
neither pretreatment with thapsigargin nor inclusion of a high
concentration of EGTA in the pipette solution prevented ACh from
inducing an inward current also excludes the possibility that
activation of INa-ACh is secondary to a rise in
[Ca2+]c.
Although it is classically admitted that muscarinic receptors are
coupled to G proteins (40), activation of INa-ACh was unaffected by inactivation of Gi/Go proteins by
pertussis toxin pretreatment or infusing -cells with GTP- -S or
GDP- -S, two guanine nucleotide analogues that, respectively,
activate and inhibit G proteins. However, both analogues were effective
in our experimental conditions as shown by their modulation of
ACh-induced inhibition of the voltage-dependent
Ca2+ current (23). These observations unexpectedly indicate
that activation of INa-ACh does not involve G proteins in
-cells. There is growing evidence that various seven-transmembrane
metabotropic receptors can also activate transduction systems without
the involvement of G proteins (41, 42). In particular, muscarinic
agonists have been found to activate, in a G protein-independent way, a Na+ current in ventricular myocytes (31), a cationic
current in CA3 pyramidal cells (43), and a K+ current in
aortic endothelial cells (44, 45). The transduction mechanisms have not
been identified, but direct or indirect (via adaptor proteins)
interactions between the receptor and effector proteins have
tentatively been proposed. Activation of cationic conductance by a Src
tyrosine kinase in CA3 pyramidal neurons (41) and facilitation of the
stimulation of inositol 1,4,5-trisphosphate receptors by the protein
Homer (42) are two examples of G protein-independent events linked to
activation of metabotropic glutamate receptor.
Role of INa-ACh in the Control of -Cell Membrane
Potential by ACh--
Apart from the increase in Na+
conductance, all of the plausible mechanisms by which ACh might
depolarize the -cell membrane can be excluded. First, ACh does not
decrease the -cell membrane K+ conductance. Unlike
glucose and sulfonylureas, ACh does not inhibit the efflux of
86Rb+ (a tracer of K+) (12, 46) and
does not reduce K+-ATP (17) or other K+
currents (this study). Second, an increase in Cl
permeability, which would depolarize the -cell membrane because of
the high equilibrium potential for Cl (19, 20), is not
involved. Thus, ACh has no effect on 86Cl
efflux from mouse islets (14, 47), and its depolarizing effect is not
influenced by omission of extracellular Cl (47). Third,
there is no evidence that ACh directly activates Ca2+
channels. On the contrary, we confirm here that high concentrations of
the neurotransmitter rather inhibit Ca2+ currents through
voltage-dependent Ca2+ channels (23). It is
possible, however, that the small capacitative Ca2+ entry
induced by ACh, via a lowering of intracellular Ca2+
stores, slightly contributes to the depolarization. Fourth, blockade of
the Na+/K+ pump is known to depolarize
-cells (24). However, several arguments suggest that ACh does not
inhibit the Na+/K+ pump. A depolarizing effect
of ACh persisted after inhibition of the Na+/K+
ATPase by omission of extracellular K+, and reactivation of
the Na+/K+ pump after its blockade (by
K+ removal or ouabain) induced a transient repolarization
that was not suppressed by
ACh.2 Moreover, ACh slightly
increased initial 86Rb+ uptake (14), which is
opposite to the effect observed after blockade of the pump with ouabain
(48, 49).
Activation of INa-ACh is therefore the most plausible
mechanism of ACh-induced depolarization of -cells. Our proposal is in complete agreement with the observation that this depolarization is
abrogated by extracellular Na+ omission but insensitive to
tetrodotoxin (12). We further show here that the amplitude of
INa-ACh is sufficient to explain the effects of ACh on the
membrane potential. Thus, injection of a current with an amplitude
similar to that activated by 1 µmol/liter of ACh (i.e.
0.23 ± 0.02 pA/pF) elicited electrical activity in cells
perifused with a subthreshold glucose concentration. Because the effect
of a given current augments with the resistance of the membrane and
because the latter increases with the glucose concentration (closure of
K+-ATP channels), it can be anticipated that even smaller
currents could depolarize the plasma membrane in the presence of
stimulating glucose concentrations. The subsequent activation of
voltage-dependent Ca2+ channels eventually
leads to a sustained increase in [Ca2+]c that
largely contributes to the insulin-releasing action of ACh (10).
 |
FOOTNOTES |
*
This work was supported by Grant 3.4552.98 from the Fonds de
la Recherche Scientifique Médicale (Brussels), Grant 1.5.121.00 from the Fonds National de la Recherche Scientifique (Brussels), Grant
2.4599.01 from the Fonds de la Recherche Fondamentale Collective (Brussels), Grant ARC 00/05-260 from the General Direction of Scientific Research of the French Community of Belgium, and the Interuniversity Poles of Attraction Program (P5/3-20), Federal Office
for Scientific, Technical and Cultural Affairs of Belgium.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Senior Research associate of the Fonds National de la
Recherche Scientifique (Brussels). To whom correspondence should be addressed: Unité d'Endocrinologie et Métabolisme,
University of Louvain Faculty of Medicine, UCL 55.30, Av. Hippocrate
55, B-1200 Brussels, Belgium. Tel.: 32-2-764-95-79; Fax:
32-2-764-55-32; E-mail: gilon@endo.ucl.ac.be.
Published, JBC Papers in Press, August 2, 2002, DOI 10.1074/jbc.M203888200
2
J.-F. Rolland, J.-C. Henquin, and P. Gilon, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
[Ca2+]c, free cytosolic calcium concentration;
ACh, acetylcholine;
K+-ATP channels, ATP-sensitive
potassium channels;
DIDS, 4,4'-diisothiocyanostilbene-2,2'-disulfonic
acid;
INa-ACh, Na+ current activated by ACh;
[Na+]c, free cytosolic sodium concentration;
F, farad;
GTP- -S, guanosine-5'-O-(3-thiotriphosphate);
GDP- -S, guanosine-5'-O-(2-thiodiphosphate).
 |
REFERENCES |
| 1.
|
Ashcroft, F. M.,
and Rorsman, P.
(1989)
Prog. Biophys. Mol. Biol.
54,
87-143[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Gilon, P.,
Ravier, M. A.,
Jonas, J. C.,
and Henquin, J. C.
(2002)
Diabetes
51,
S144-S151[Abstract/Free Full Text]
|
| 3.
|
Maechler, P.,
and Wollheim, C. B.
(2001)
Nature
414,
807-812[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Matschinsky, F. M.
(1996)
Diabetes
45,
223-241[Abstract]
|
| 5.
|
Seino, S.,
Iwanaga, T.,
Nagashima, K.,
and Miki, T.
(2000)
Diabetes
49,
311-318[Abstract]
|
| 6.
|
Aizawa, T.,
Komatsu, M.,
Asanuma, N.,
Sato, Y.,
and Sharp, G. W.
(1998)
Trends Pharmacol. Sci.
19,
496-499[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Henquin, J. C.
(2000)
Diabetes
49,
1751-1760[Abstract]
|
| 8.
|
Ahren, B.
(2000)
Diabetologia
43,
393-410[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Brunicardi, F. C.,
Sun, Y. S.,
Druck, P.,
Goulet, R. J.,
Elahi, D.,
and Andersen, D. K.
(1987)
Am. J. Surg.
153,
34-40[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Gilon, P.,
and Henquin, J. C.
(2001)
Endocr. Rev.
22,
565-604[Abstract/Free Full Text]
|
| 11.
|
Satin, L. S.,
and Kinard, T. A.
(1998)
Endocrine
8,
213-223[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Henquin, J. C.,
Garcia, M. C.,
Bozem, M.,
Hermans, M. P.,
and Nenquin, M.
(1988)
Endocrinology
122,
2134-2142[Abstract/Free Full Text]
|
| 13.
|
Saha, S.,
and Hellman, B.
(1991)
Eur. J. Pharmacol.
204,
211-215[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Gagerman, E.,
Sehlin, J.,
and Taljedal, I. B.
(1980)
J. Physiol.
300,
505-513[Abstract/Free Full Text]
|
| 15.
|
Gilon, P.,
and Henquin, J. C.
(1993)
FEBS Lett.
315,
353-356[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Meissner, H. P.
(1990)
Methods Enzymol.
192,
235-246[Medline]
[Order article via Infotrieve]
|
| 17.
|
Rolland, J. F.,
Henquin, J. C.,
and Gilon, P.
(2002)
Diabetes
51,
376-384[Abstract/Free Full Text]
|
| 18.
|
Gilon, P.,
Nenquin, M.,
and Henquin, J. C.
(1995)
Biochem. J.
311,
259-267[Medline]
[Order article via Infotrieve]
|
| 19.
|
Eberhardson, M.,
Patterson, S.,
and Grapengiesser, E.
(2000)
Cell Signal.
12,
781-786[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Sehlin, J.
(1978)
Am. J. Physiol.
235,
E501-E508[Medline]
[Order article via Infotrieve]
|
| 21.
|
Best, L.,
Brown, P. D.,
Sheader, E. A.,
and Yates, A. P.
(2000)
J. Membr. Biol.
177,
169-175[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Kinard, T. A.,
and Satin, L. S.
(1995)
Diabetes
44,
1461-1466[Abstract]
|
| 23.
|
Gilon, P.,
Yakel, J.,
Gromada, J.,
Zhu, Y.,
Henquin, J. C.,
and Rorsman, P.
(1997)
J. Physiol.
499,
65-76[Abstract/Free Full Text]
|
| 24.
|
Henquin, J. C.,
and Meissner, H. P.
(1982)
J. Physiol.
332,
529-552[Abstract/Free Full Text]
|
| 25.
|
Miura, Y.,
Gilon, P.,
and Henquin, J. C.
(1996)
Biochem. Biophys. Res. Commun.
224,
67-73[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Heimberg, H., De,
Vos, A.,
Pipeleers, D.,
Thorens, B.,
and Schuit, F.
(1995)
J. Biol. Chem.
270,
8971-8975[Abstract/Free Full Text]
|
| 27.
|
Iacono, G.,
and Vassalle, M.
(1989)
Am. J. Physiol.
256,
H1407-H1416[Medline]
[Order article via Infotrieve]
|
| 28.
|
Hosey, M. M.
(1992)
FASEB J.
6,
845-852[Abstract]
|
| 29.
|
Hucho, F.
(1986)
Eur. J. Biochem.
158,
211-226[Medline]
[Order article via Infotrieve]
|
| 30.
|
Matsumoto, K.,
and Pappano, A. J.
(1989)
J. Physiol.
415,
487-502[Abstract/Free Full Text]
|
| 31.
|
Shirayama, T.,
Matsumoto, K.,
and Pappano, A. J.
(1993)
J. Pharmacol. Exp. Ther.
265,
641-648[Abstract/Free Full Text]
|
| 32.
|
Inoue, R.,
and Isenberg, G.
(1990)
Am. J. Physiol.
258,
C1173-C1178[Medline]
[Order article via Infotrieve]
|
| 33.
|
Benham, C. D.,
Bolton, T. B.,
and Lang, R. J.
(1985)
Nature
316,
345-347[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Inoue, M.,
Sakamoto, Y.,
and Imanaga, I.
(1995)
Eur. J. Pharmacol.
276,
123-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Carroll, R. C.,
and Peralta, E. G.
(1998)
EMBO J.
17,
3036-3044[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Plant, T. D.
(1988)
Pfluegers Arch. Eur. J. Physiol.
411,
429-435[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Putney, J. W., Jr.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14669-14671[Free Full Text]
|
| 38.
|
Tepel, M.,
Wischniowski, H.,
and Zidek, W.
(1994)
Biochim. Biophys. Acta
1220,
248-252[Medline]
[Order article via Infotrieve]
|
| 39.
|
Worley, J. F., III,
McIntyre, M. S.,
Spencer, B.,
and Dukes, I. D.
(1994)
J. Biol. Chem.
269,
32055-32058[Abstract/Free Full Text]
|
| 40.
|
Wess, J.,
Blin, N.,
Mutschler, E.,
and Bluml, K.
(1995)
Life Sci.
56,
915-922[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Heuss, C.,
and Gerber, U.
(2000)
Trends Neurosci.
23,
469-475[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Brzostowski, J. A.,
and Kimmel, A. R.
(2001)
Trends Biochem. Sci.
26,
291-297[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Guerineau, N. C.,
Bossu, J. L.,
Gahwiler, B. H.,
and Gerber, U.
(1995)
J. Neurosci.
15,
4395-4407[Abstract]
|
| 44.
|
Olesen, S. P.,
Davies, P. F.,
and Clapham, D. E.
(1988)
Circ. Res.
62,
1059-1064[Abstract/Free Full Text]
|
| 45.
|
Brown, L. D.,
Kim, K. M.,
Nakajima, Y.,
and Nakajima, S.
(1993)
Brain Res.
612,
200-209[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Nenquin, M.,
Awouters, P.,
Mathot, F.,
and Henquin, J. C.
(1984)
FEBS Lett.
176,
457-461[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Hermans, M. P.,
Schmeer, W.,
Gerard, M.,
and Henquin, J. C.
(1991)
Biochim. Biophys. Acta
1092,
205-210[Medline]
[Order article via Infotrieve]
|
| 48.
|
Sehlin, J.,
and Taljedal, I. B.
(1974)
J. Physiol.
242,
505-515[Abstract/Free Full Text]
|
| 49.
|
Henquin, J. C.
(1980)
Biochem. J.
186,
541-550[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Gilbert, S.-R. Jung, B. J. Reed, and I. R. Sweet
Islet Oxygen Consumption and Insulin Secretion Tightly Coupled to Calcium Derived from L-type Calcium Channels but Not from the Endoplasmic Reticulum
J. Biol. Chem.,
September 5, 2008;
283(36):
24334 - 24342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Tarasov, H. J. Welters, S. Senkel, G. U. Ryffel, A. T. Hattersley, N. G. Morgan, and F. M. Ashcroft
A Kir6.2 Mutation Causing Neonatal Diabetes Impairs Electrical Activity and Insulin Secretion From INS-1 {beta}-Cells
Diabetes,
November 1, 2006;
55(11):
3075 - 3082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ashcroft and P. Rorsman
Type 2 diabetes mellitus: not quite exciting enough?
Hum. Mol. Genet.,
April 1, 2004;
13(suppl_1):
R21 - R31.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|